Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2010
10/26/2010US7820657 receptor kinase inhibitors such as 3-(2-{4-[3-(5-tert-Butyl-isoxazol-3-yl)-ureido]-phenyl}-benzo[d]imidazo[2,1-b]thiazol-7-yl)-N-(2-morpholin-4-yl-ethyl)-propionamide; flk inhibitors
10/26/2010US7820654 such as 1-[2-(3-Chloro-4-methoxy-phenylamino)-6-phenyl-pyrimidin-4-yl]-piperidin-4-ol for treating atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by low expression of Perlecan
10/26/2010US7820646 Anticancer agents; antiproliferative agents; using an substituted aimidazole compound
10/26/2010US7820159 Using epidermal growth factor receptor as tool in identifying modulators for prevention and treatment of cell proliferative disorders
10/26/2010US7820144 Receptor selective cannabimimetic aminoalkylindoles
10/26/2010CA2598725C Fused aromatic compounds having anti-diabetic activity
10/26/2010CA2353627C Picolinamide derivative and harmful organism control agent comprising said picolinamide derivative as active component
10/26/2010CA2293436C Imidazolyl-cyclic acetals as tnf inhibitors
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/21/2010WO2010121164A2 1,4-benzodiazepinone compounds and their use in treating cancer
10/21/2010WO2010121046A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010WO2010121036A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010WO2010121011A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010WO2010120987A1 Ring fused, ureidoaryl- and carbamoylaryl-bridged morpholino-pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
10/21/2010WO2010120935A1 Anti-viral compounds
10/21/2010WO2010120910A1 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
10/21/2010WO2010120237A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
10/21/2010WO2010119700A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
10/21/2010WO2010077101A3 Novel thiazolidinedione derivative and use thereof
10/21/2010US20100267950 Novel Stabilizing Ligands For Regulation of Protein Function
10/21/2010US20100267949 Method of Synthesizing 6,7-Substituted 4-Anilino Quinazoline
10/21/2010US20100267947 Exo-selective synthesis of himbacine analogs
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267800 N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses
10/21/2010US20100267793 Method of treatment using n3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267775 Oxadiazolidinedione compound
10/21/2010US20100267740 Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators - 842
10/21/2010US20100267725 Compounds, Compositions and Methods Comprising 4N-Substituted Triazole Derivatives
10/21/2010US20100267724 S-triazole alpha-mercaptoacetanilides as inhibitors of hiv reverse transcriptase
10/21/2010US20100267723 Imidazole Substituted Pyrimidines
10/21/2010US20100267722 Novel proline derivatives
10/21/2010US20100267721 Heterocyclic H3 Antagonists
10/21/2010US20100267720 Crystalline Forms of 2-Hydroxy-3- [5- (Morpholin- 4- Ylmethyl) Pyridin-2-YL] IH- Indole- 5 -Carbonitrile Citrate
10/21/2010US20100267719 Enhanced Indolinone Based Protein Kinase Inhibitors
10/21/2010US20100267718 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/21/2010US20100267714 Mif modulators
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267710 N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267707 Tyrosine Kinase Inhibitors
10/21/2010US20100267706 Compounds, Compositions and Methods Comprising Pyridazine Derivatives
10/21/2010US20100267700 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
10/21/2010US20100267698 Benzimidazole and Pyridylimidazole Derivatives
10/21/2010US20100267697 Ion channel modulators
10/21/2010US20100267689 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010US20100267688 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010US20100267687 Phenylpyrazole derivatives
10/21/2010US20100267685 Methods For The Prophylaxis And/or Treatment Of Thromboembolic Disorders By Combination Therapy With Substituted Oxazolidinones
10/21/2010US20100267671 Compositions and methods for apoptosis modulators
10/21/2010US20100267634 Anti-Viral Compounds
10/21/2010US20100267561 Herbicidal pyridazinone derivatives
10/21/2010US20100266714 P2x3 receptor antagonists for treatment of pain
10/21/2010US20100266543 Linked dibenzimidazole antivirals
10/21/2010US20100266509 Heteroaryl amide analogues as p2x7 antagonists
10/21/2010CA2761064A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
10/21/2010CA2758934A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010CA2758929A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010CA2758918A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
10/21/2010CA2758484A1 Anti-viral compounds
10/20/2010EP2241557A1 Chinoxalin derivatives and use thereof for treating malignant and benign tumour illnesses
10/20/2010EP2240468A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
10/20/2010EP2240178A1 Prolyl hydroxylase inhibitors
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP2144897B1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/20/2010EP1984331B1 Pyrrolidine derivatives as erk inhibitors
10/20/2010EP1924570B1 Azole and thiazole derivatives and their use
10/20/2010EP1789377B1 Alternative synthesis of renin inhibitors and intermediates thereof
10/20/2010EP1722798B1 Pyrimidine compounds as purine receptor antagonists
10/20/2010EP0959075B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
10/20/2010CN101868458A Isoxazolo-pyridazine derivatives
10/20/2010CN101868457A (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
10/20/2010CN101868456A Pyridine compound, pesticidal composition and method of controlling pest
10/20/2010CN101868455A Therapeutic substituted lactams
10/20/2010CN101868451A Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
10/20/2010CN101863884A 4, 5-dihydro-oxazole aniline compound and application thereof
10/20/2010CN101863877A Therapeutic agents useful for treating pain
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816529 Sodium and calcium channel antagonists; higher potency; fewer side effects to central nervous system
10/19/2010US7816521 1,2,4-benzotriazine-1,4-dioxides
10/19/2010US7816380 1-hydroxycycloalkanecarboxamide derivatives
10/19/2010US7816379 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes torezolid phosphate
10/19/2010US7816376 Use as excitatory amino acid antagonists for combating neurodegenerative and cerebrovascular diseases, epilepsy, schizophrenia, Alzheimer's, Parkinson's or Huntington's disease, or psychoses; for example, 3-[4-(3,4-methylenedioxybenzyl)piperidino]-N-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propionamide
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/19/2010US7816369 Mediators of hedgehog signaling pathways, compositions and uses related thereto
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816361 such as 4-(5-Oxo-3-pyrazin-2-yl-2,5-dihydro-pyrazol-1-yl)-N-(1,2,2,6,6-pentamethyl-piperidin-4-yl)-benzamide, used as immunomodulators for the treatment of rheumatoid arthritis, psoriasis, multiple sclerosis and diabetes
10/19/2010US7816360 MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
10/19/2010US7816355 Processes for the preparation of rivaroxaban and intermediates thereof
10/19/2010US7816354 4'-(2-Oxo-5-(R)-phenyl-oxazolidin-3-ylmethyl) biphenyl-3-carboxylic acid (2-dimethylamino-ethyl)-amide, usedd for the treatment or prevention of neurological and psychiatric disorders
10/19/2010US7816353 P70S6 kinase modulators and method of use
10/19/2010US7816351 Prevent proliferation of hepatitis C virus; low toxicity
10/19/2010US7816349 (R)-3-{3,5-Dichloro-4'-[4-(2-fluoro-ethyl)-piperazine-1-carbonyl]-biphenyl-4-ylmethyl}-1-(4,4-difluoro-cyclohexyl)-pyrrolidin-2-one, used for the treatment of diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome and cognitive disorders
10/19/2010CA2469346C Substituted 2-pyrrolidin-2-yl-1h-indole derivatives for treatment of migraine
10/19/2010CA2464367C Bicyclic compounds
10/19/2010CA2393158C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/19/2010CA2214338C Use of .alpha.1l agonists for treating urinary incontinence
10/14/2010WO2010118208A1 Benzoxazepin-4- (5h) -yl derivatives and their use to treat cancer
10/14/2010WO2010117932A1 Indole derivatives and methods for antiviral treatment
10/14/2010WO2010117704A1 Hepatitis c virus inhibitors
10/14/2010WO2010117323A1 Method and apparatus for producing heat energy and carbon dioxide
1 ... 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 ... 647